21 results
8-K
EX-14.1
DAWN
Day One Biopharmaceuticals, Inc.
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
) or practices (such as discipline, compensation or benefits) on the basis of any protected characteristic, including race, color, religion, sex, gender
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals, Inc.
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
% Optic pathway Median age, years (range) 8 (2-21) 51% Gender, n (%) Other Male 40 (52) † 16% Female 37 (48) Cerebral hemisphere Race, n (%) 8% Cerebellum
S-3ASR
EX-4.4
wawlk7r
14 Sep 23
Automatic shelf registration
5:28pm
8-K
EX-1.1
rbjzw69 omutk4
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm
PRE 14A
pryoa8yyg5chk
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-1.1
1apx4p3e4
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
S-3
EX-1.2
amf4iys5
1 Jun 22
Shelf registration
4:06pm
S-3
EX-4.4
bs6na uunv
1 Jun 22
Shelf registration
4:06pm
DEF 14A
db1sjn7pn3b
28 Apr 22
Definitive proxy
4:44pm
S-1/A
EX-1.1
d1ltq6xkvj
24 May 21
IPO registration (amended)
6:16am
S-1/A
EX-3.1
ffd2haf0qp jtuottxt
24 May 21
IPO registration (amended)
6:16am
S-1
EX-10.5
a7mat5
4 May 21
IPO registration
4:12pm
S-1
EX-10.6
sw6lc4 i9
4 May 21
IPO registration
4:12pm
S-1
EX-10.7
gjvb2d3al vb
4 May 21
IPO registration
4:12pm
S-1
EX-3.1
xwkp8x9g
4 May 21
IPO registration
4:12pm
S-1
EX-10.4
g3w1c udr
4 May 21
IPO registration
4:12pm